![logo](/logos/PEB.NZ.webp)
Pacific Edge Limited
NZX:PEB.NZ
0.1 (NZD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Pacific Edge Limited |
Symbool | PEB.NZ |
Munteenheid | NZD |
Prijs | 0.102 |
Beurswaarde | 82,657,229 |
Dividendpercentage | 0% |
52-weken bereik | 0.05 - 0.56 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Peter Meintjes |
Website | https://www.pacificedgedx.com |
An error occurred while fetching data.
Over Pacific Edge Limited
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (NZD)
Cijfers zijn in miljoenen (NZD)